Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Proliferation and apoptosis must be precisely regulated to form organs with appropriate cell numbers and to avoid tumour growth. Here we show that Hippo (Hpo), the Drosophila homologue of the mammalian Ste20-like kinases, MST1/2, promotes proper termination of cell proliferation and stimulates apoptosis during development. hpo mutant tissues are larger than normal because mutant cells continue to proliferate beyond normal tissue size and are resistant to apoptotic stimuli that usually eliminate extra cells. Hpo negatively regulates expression of Cyclin E to restrict cell proliferation, downregulates the Drosophila inhibitor of apoptosis protein DIAP1, and induces the proapoptotic gene head involution defective (hid) to promote apoptosis. The mutant phenotypes of hpo are similar to those of warts (wts), which encodes a serine/threonine kinase of the myotonic dystrophy protein kinase family, and salvador (sav), which encodes a WW domain protein that binds to Wts. We find that Sav binds to a regulatory domain of Hpo that is essential for its function, indicating that Hpo acts together with Sav and Wts in a signalling module that coordinately regulates cell proliferation and apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,612
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977 · cited 1×
“The mutant phenotypes of hpo are similar to those of warts ( wts ), which encodes a serine/threonine kinase of the myotonic dystrophy protein kinase famil”
BackgroundTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 1×
“, and salvador ( sav ), which encodes a WW domain protein that binds to Wt”
BackgroundXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Coordination of Growth and Cell Division in the Drosophila Wing
Neufeld, T. P., de la Cruz, A. F. A., Johnston, L. A., & Edgar, B. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81462-2 · Cited by 769 · cited 1×
“jpg" NDATA ITEM> ]> Proliferation and apoptosis must be precisely regulated to form organs with appropriate cell numbers and to avoid tumour growt”
BackgroundSize Control in Animal Development
Conlon, I., & Raff, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80563-2 · Cited by 743
The head involution defective gene of Drosophila melanogaster functions in programmed cell death.
Grether, M. E., Abrams, J. M., Agapite, J., White, K., & Steller, H. (1995) · Genes & Development · doi:10.1101/gad.9.14.1694 · Cited by 699 · cited 1×
“Overexpression of Hid in the developing eye induces apoptosis and results in loss of eye structure”
BackgroundThe Ste20 group kinases as regulators of MAP kinase cascades
Dan, I., Watanabe, N. M., & Kusumi, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01980-8 · Cited by 627 · cited 1×
“Here we show that Hippo (Hpo), the Drosophila homologue of the mammalian Ste20-like kinase”
BackgroundAnalysis of Drosophila photoreceptor axon guidance in eye-specific mosaics
Newsome, T. P., Åsling, B., & Dickson, B. J. (2000) · Development · doi:10.1242/dev.127.4.851 · Cited by 625
Cited by
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
“Hippo (Hpo) is a Ste20 family protein kinase that complexes with a regulatory scaffold protein Salvador (Sav) (Kango-Singh et al. 2002; Tapon et al. 2002; Harvey et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003).”
BackgroundSelf-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
“Yki induces expression of genes like cyclin E and Diap1, and therefore promotes proliferation and inhibits apoptosis (Udan et al. 2003; Huang et al. 2005).”
BackgroundThe Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
“…domain-containing protein Salvador (Sav) (Tapon et al., 2002; Kango-Singh et al., 2002), the Ste20like protein kinase Hippo (Hpo) (Wu et al., 2003; Udan et al., 2003; Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003) and the adaptor protein Mob-as-tumor-suppressor (Mats) (Lai et…”
BackgroundHippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
“…that Salvador (sav) (Kango-Singh et al., 2002; Tapon et al., 2002), Hippo (hpo) (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003), and Mob as tumor suppressor (mats) (Lai et al., 2005) mutant Drosophila phenocopy wts mutants with regards to…”
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
“S4; Westbrook et al. 2008).”
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
“…of genes, including Warts (Wts) (Justice et al. 1995; Xu et al. 1995), Hippo (Hpo) (Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003), Salvador (Sav; also known as Shar-Pei) (KangoSingh et al. 2002; Tapon et al. 2002), and Mats (Lai et al. 2005),…”
BackgroundInfluentialThe Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
“sav (shar-pei) encoding a WW domain-containing protein and hippo (hpo) encoding a STE20 family protein kinase are two other Hippo pathway components identified in a similar fashion to that of wts (Kango-Singh et al. 2002; Tapon et al. 2002; Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003;…”
BackgroundHippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Self-citationTransduction of mechanical and cytoskeletal cues by YAP and TAZ
Halder, G., Dupont, S., & Piccolo, S. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3416 · Cited by 985
Self-citationHippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Self-citationZhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
“Loss of Hippo function (in the fly eye) results in massive overgrowth, due to an acceleration of cell cycle progression and a failure of developmental apoptosis (Harvey et al., 2003; Udan et al., 2003; Wu et al., 2003); Mst2 can complement Hippo loss of function (Wu et al., 2003).”
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
“The Drosophila YAP homolog Yki is required for this response 26252724 , but unlike in mammals, Yki is activated in differentiated enterocytes which drives the expression of cytokines that then signal to stem cells and promote their proliferation 24 .”
InfluentialSelf-citationThe Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“, 2002), hippo (hpo) (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003), and mob as tumor suppressor (mats) (Lai et al.”
BackgroundTargeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
“At the core of the Hippo signaling pathway is a kinase cascade composed of four tumor suppressor proteins, including the Ste20-like kinase Hippo (Hpo) (Wu et al., 2003; Udan et al., 2003; Harvey et al., 2003; Pantalacci et al., 2003; Jia et al., 2003) and its regulatory protein Salvador (Sav) (Tapon et al.”
BackgroundCell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Zhao, B., Li, L., Wang, L., Wang, C.-Y., Yu, J., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.173435.111 · Cited by 793
“…pathway that limits organ size under physiological conditions (Justice et al. 1995; Xu et al. 1995; Kango-Singh et al. 2002; Tapon et al. 2002; Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003; Huang et al. 2005; Lai et al. 2005; Dong et al. 2007).”
BackgroundTumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Self-citationThe Hippo signaling pathway in stem cell biology and cancer
Mo, J., Park, H. W., & Guan, K. (2014) · EMBO reports · doi:10.15252/embr.201438638 · Cited by 674
“In Drosophila, the core components of the Hippo pathway include the kinase cascade of Ste20-like kinase Hpo (Hippo) and NDR family kinase Wts (Warts) [1–7].”
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development · doi:10.1242/dev.102376 · Cited by 665
“The Hippo pathway was identified in genetic studies of Drosophila melanogaster as a suppressor of tissue overgrowth (Huang et al., 2005; Jia et al., 2003; Justice et al., 1995; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003).”
BackgroundAngiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q., & Guan, K.-L. (2011) · Genes & Development · doi:10.1101/gad.2000111 · Cited by 665
“…mutation of the Hippo pathway genes or transgenic expression of Yki, the YAP homolog, results in enlarged organ size (Kango-Singh et al. 2002; Tapon et al. 2002; Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003; Huang et al. 2005; Lai et al. 2005).”
BackgroundHippo signaling in organ size control
Pan, D. (2007) · Genes & Development · doi:10.1101/gad.1536007 · Cited by 647
“…the genesis of the Hpo pathway was the identification of the Hpo tumor suppressor gene (Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003), which encodes a Ste-20 family protein kinase with a similar loss-of-function overgrowth phenotype to that reported…”
BackgroundMechanical regulation of bone remodeling
Wang, L., You, X., Zhang, L., Zhang, C., & Zou, W. (2022) · Bone Research · doi:10.1038/s41413-022-00190-4 · Cited by 641
“In mammals, MST1/2 form heterodimers with SAV1 through their C-terminal SARAH domains, after which MST1/2 can phosphorylate SAV1, MOB1, and LATS1/2 kinase.(176,177) LATS1/2 directly phosphorylates YAP and TAZ at multiple sites, thereby inhibiting their nuclear localization.”
BackgroundThe TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630
“Loss-of-function mutations in the hpo pathway components including hpo, sav, and wts resulted in similar tissue overgrowth phenotypes (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003).”
BackgroundThe Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
“Hpo may also negatively regulate diap1 at the transcriptional level (Udan et al., 2003; Wu et al., 2003).”
BackgroundExpression of Yes-associated protein in common solid tumors
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., & Anders, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.012 · Cited by 552
“Hippo (Hpo) and Warts (Wts), 2 significant core pathway components, belong to the Sterile 20 (Ste20) and Nuclear Dbf2-related (NDR) serine/threonine protein kinase families, respectively [7,9-13].”
BackgroundCancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 548
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Meng, Z., Moroishi, T., Mottier-Pavie, V., Plouffe, S. W., Hansen, C. G., Hong, A. W., Park, H. W., Mo, J.-S., Lu, W., Lu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9357 · Cited by 530
Self-citationLiu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152942 · Cited by 525
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.-M., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.012 · Cited by 496
“Central to the Hippo pathway is a kinase cascade comprised of four tumor suppressors, including the Ste20-like kinase Hippo (Hpo) (Wu et al., 2003; Udan et al., 2003; Harvey et al., 2003; Pantalacci et al., 2003; Jia et al., 2003) and its regulatory protein Salvador (Sav) (Tapon et al.”
Interplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K.-L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 472
The Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
Goulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J., & Zider, A. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.034 · Cited by 452
“This pathway consists of the two serine-threonine kinases, HIPPO [9, 10] and WARTS (WTS, also known as Large Tumor Suppressor) [11], the adaptator molecules SALVADOR (SAV) [11, 12] and Mob as Tumor Suppressor (MATS) [13], the FERM domain proteins EXPANDED (EX) and MERLIN (MER) [14], and the protocadherin FAT (FT) [15].”
BackgroundZeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
“Subsequent studies uncovered the Hippo (Hpo) component and placed Hippo upstream of Wts (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) and established that Sav potentiates the activity of Hippo (Wu et al., 2003).”
BackgroundDelineation of a Fat tumor suppressor pathway
Cho, E., Feng, Y., Rauskolb, C., Maitra, S., Fehon, R., & Irvine, K. D. (2006) · Nature Genetics · doi:10.1038/ng1887 · Cited by 432
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
Sansores‐Garcia, L., Bossuyt, W., Wada, K., Yonemura, S., Tao, C., Sasaki, H., & Halder, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.157 · Cited by 430
“…stocks: hh-Gal4, dpp-Gal4, 30A-Gal4, en-Gal4, ap-Gal4, gmr-Gal4, UAS-yki (Huang et al, 2005), UAS-DiaCA (Somogyi and Rorth, 2004), UAS-cpaRNAi (VDRC: TID 100773), UAS-cpbRNAi (VDRC: TID 45668), UAS-GFP, UAS-hpo (Udan et al, 2003), UAS-exe1 (Boedigheimer et al, 1997), UAS-wts (Udan et al, 2003).”
BackgroundMethodSelf-citationMatallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
“In Drosophila, YAP1 enhances the expression of dIAP (inhibitor of apoptosis) and cyclin E (Harvey et al., 2003; Udan et al., 2003; Wu et al., 2003).”
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Enzo, E., Santinon, G., Pocaterra, A., Aragona, M., Bresolin, S., Forcato, M., Grifoni, D., Pession, A., Zanconato, F., Guzzo, G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490379 · Cited by 414
Thompson, B. J., & Cohen, S. M. (2006) · Cell · doi:10.1016/j.cell.2006.07.013 · Cited by 398
“The overgrown eyes consist of an abnormally large number of cells, which characteristically accumulate between the photoreceptor-containing ommatidial facets that compose the eye (for example, Udan et al., 2003).”
InfluentialOta, M., & Sasaki, H. (2008) · Development · doi:10.1242/dev.027151 · Cited by 391
“The core components of this pathway are an Ste20-like kinase Hippo (Hpo) (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) and its regulatory protein Salvador (Tapon et al.”
BackgroundA molecular mechanism that links Hippo signalling to the inhibition of Wnt/β‐catenin signalling
Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A., & Nishida, E. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.487 · Cited by 378
“…types of tumour suppressors: the Ste20-like kinases MST1/2 (Hippo in Drosophila ) (Harvey et al , 2003; Jia et al , 2003; Pantalacci et al , 2003; Udan et al , 2003; Wu et al , 2003), its regulatory protein WW45 (Salvador) (Kango-Singh et al , 2002; Tapon et al , 2002), the NDR family kinases…”
Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
Oka, T., Mazack, V., & Sudol, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804380200 · Cited by 367
Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 363
Vaccari, T., & Bilder, D. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.019 · Cited by 363
“This phenotype is reminiscent of that caused by mutations in certain Drosophila hyperplastic tumor suppressor genes such as hippo, salvador, and warts/ lats (Jia et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003; Xu et al., 1995).”
BackgroundZhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360
PRASKOVA, M., KHOKLATCHEV, A., ORTIZ-VEGA, S., & AVRUCH, J. (2004) · Biochemical Journal · doi:10.1042/bj20040025 · Cited by 342
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Yu, F.-X., Zhang, Y., Park, H. W., Jewell, J. L., Chen, Q., Deng, Y., Pan, D., Taylor, S. S., Lai, Z.-C., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.219402.113 · Cited by 337
“Core components of the Hippo pathway were first established in Drosophila and later shown to be highly conserved in mammals (Justice et al. 1995; Xu et al. 1995; Kango-Singh et al. 2002; Tapon et al. 2002; Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003; Huang et al. 2005;…”
BackgroundFrom Cell Structure to Transcription: Hippo Forges a New Path
Edgar, B. A. (2006) · Cell · doi:10.1016/j.cell.2006.01.005 · Cited by 331
“Downstream of Hippo and Warts Targeted searches for downstream effectors revealed that the loss of hpo, sav, wts, or mats caused a cell-autonomous increase in the amounts of the Drosophila inhibitor of apoptosis gene product, DIAP-1, and the cell cycle regulator Cyclin E (Harvey et al., 2003; Pantalacci et al., 2003;…”
InfluentialThe Fat Cadherin Acts through the Hippo Tumor-Suppressor Pathway to Regulate Tissue Size
Willecke, M., Hamaratoglu, F., Kango-Singh, M., Udan, R., Chen, C.-L., Tao, C., Zhang, X., & Halder, G. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.005 · Cited by 329
Self-citationThe Hippo pathway in intestinal regeneration and disease
Hong, A. W., Meng, Z., & Guan, K.-L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.59 · Cited by 326
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
NDR kinases regulate essential cell processes from yeast to humans
Hergovich, A., Stegert, M. R., Schmitz, D., & Hemmings, B. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1891 · Cited by 323
The WW Domain Protein Kibra Acts Upstream of Hippo in Drosophila
Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E., & Stocker, H. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.013 · Cited by 320
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
DeRan, M., Yang, J., Shen, C.-H., Peters, E. C., Fitamant, J., Chan, P., Hsieh, M., Zhu, S., Asara, J. M., Zheng, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.036 · Cited by 316
“Subsequently, Lats1/ Lats2 kinases in complex with Mob1 phosphorylate YAP/TAZ, leading to their cytoplasmic retention and inhibition (Harvey et al., 2003; Udan et al., 2003; Wu et al., 2003).”
Fat Cadherin Modulates Organ Size in Drosophila via the Salvador/Warts/Hippo Signaling Pathway
Bennett, F. C., & Harvey, K. F. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.045 · Cited by 314
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Glycogen accumulation and phase separation drives liver tumor initiation
Liu, Q., Li, J., Zhang, W., Xiao, C., Zhang, S., Nian, C., Li, J., Su, D., Chen, L., Zhao, Q., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.001 · Cited by 309
Shaw, R. L., Kohlmaier, A., Polesello, C., Veelken, C., Edgar, B. A., & Tapon, N. (2010) · Development · doi:10.1242/dev.052506 · Cited by 307
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Janse van Rensburg, H. J., Azad, T., Ling, M., Hao, Y., Snetsinger, B., Khanal, P., Minassian, L. M., Graham, C. H., Rauh, M. J., & Yang, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3139 · Cited by 306
Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression
Cai, X., Wang, K.-C., & Meng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673599 · Cited by 304
The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila
Chen, C.-L., Gajewski, K. M., Hamaratoglu, F., Bossuyt, W., Sansores-Garcia, L., Tao, C., & Halder, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004060107 · Cited by 302
“The overgrowth phenotypes of crb mutant clones are similar but not as strong as those of hpo mutants (23).”
BackgroundSelf-citationThe RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
“melanogaster, which regulates cell proliferation and apoptosis [19,24].”
BackgroundActin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila
Fernández, B. G., Gaspar, P., Brás-Pereira, C., Jezowska, B., Rebelo, S. R., & Janody, F. (2011) · Development · doi:10.1242/dev.063545 · Cited by 293
“Most of the mechanosensitive responses require tethering to force-bearing actin filaments (Vogel and Sheetz, 2006).”
BackgroundSilva, E., Tsatskis, Y., Gardano, L., Tapon, N., & McNeill, H. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.004 · Cited by 290
The Hippo signaling pathway and stem cell biology
Ramos, A., & Camargo, F. D. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.006 · Cited by 287
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Noguchi, S., Saito, A., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113674 · Cited by 277
“The core components of the Hippo pathway were initially identified by genetic screens to identify tumor suppressors in Drosophila, and ‘Hippo’ originated from the morphological phenotype of a Drosophila mutant [12].”
BackgroundCallus, B. A., Verhagen, A. M., & Vaux, D. L. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05427.x · Cited by 276
Phosphoproteome Analysis of Drosophila melanogaster Embryos
Zhai, B., Villén, J., Beausoleil, S. A., Mintseris, J., & Gygi, S. P. (2008) · Journal of Proteome Research · doi:10.1021/pr700696a · Cited by 270
Mandal, S., Guptan, P., Owusu-Ansah, E., & Banerjee, U. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.11.006 · Cited by 269
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3073 · Cited by 266
The bantam MicroRNA Is a Target of the Hippo Tumor-Suppressor Pathway
Nolo, R., Morrison, C. M., Tao, C., Zhang, X., & Halder, G. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.057 · Cited by 265
“tem [38] and the following stocks: UAS-hpo [4], UAS-DIAPI (from B.”
BackgroundSelf-citationAjuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway
Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M. J., Skeath, J. B., & Longmore, G. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.02.035 · Cited by 258
Hippo signaling in Drosophila: Recent advances and insights
Staley, B. K., & Irvine, K. D. (2012) · Developmental Dynamics · doi:10.1002/dvdy.22723 · Cited by 249
“They were all first identified through genetic screens as Drosophila tumor suppressors (Justice et al., 1995; Xu et al., 1995; Kango-Singh et al., 2002; Tapon et al., 2002; Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003; Lai et al., 2005).”
BackgroundTao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway
Boggiano, J. C., Vanderzalm, P. J., & Fehon, R. G. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.028 · Cited by 249
“In animals lacking hpo or wts function, cells fail to exit the cell cycle and undergo division after the SMW, shown by BrdU incorporation during S phase (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003).”
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Chen, L., Chan, S. W., Zhang, X., Walsh, M., Lim, C. J., Hong, W., & Song, H. (2010) · Genes & Development · doi:10.1101/gad.1865310 · Cited by 249
“Activation of this pathway induces a kinase cascade that consists of a Ste20-like kinase, Hippo (Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003), and the downstream NDR family kinase Warts (Justice et al. 1995; Xu et al. 1995).”
BackgroundIdentification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
Miller, E., Yang, J., DeRan, M., Wu, C., Su, A. I., Bonamy, G. M. C., Liu, J., Peters, E. C., & Wu, X. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.005 · Cited by 246
“Initially discovered in Drosophila, Hippo signaling is an emerging tumor suppressor pathway that plays key roles in normal physiology and tumorigenesis through the regulation of cellular proliferation and survival (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; W…”
Tang, T. T., Konradi, A. W., Feng, Y., Peng, X., Ma, M., Li, J., Yu, F.-X., Guan, K.-L., & Post, L. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0717 · Cited by 245
Zhang, J., Smolen, G. A., & Haber, D. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6205 · Cited by 243
Eder, A. M., Sui, X., Rosen, D. G., Nolden, L. K., Cheng, K. W., Lahad, J. P., Kango-Singh, M., Lu, K. H., Warneke, C. L., Atkinson, E. N., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505641102 · Cited by 238
Self-citationRegulation of Imaginal Disc Growth by Tumor-Suppressor Genes in Drosophila
Hariharan, I. K., & Bilder, D. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.073003.100738 · Cited by 237
Ribeiro, P. S., Josué, F., Wepf, A., Wehr, M. C., Rinner, O., Kelly, G., Tapon, N., & Gstaiger, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.002 · Cited by 235
“…of hpo in the developing eye under the control of the Glass Multimer Reporter (GMR) promoter induces extensive apoptosis, leading to a marked reduction of adult eye size and a rough eye phenotype (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003; and Figure 5B).”
The Hippo Pathway in Liver Homeostasis and Pathophysiology
Driskill, J. H., & Pan, D. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-030420-105050 · Cited by 234
Protein kinases of the Hippo pathway: Regulation and substrates
Avruch, J., Zhou, D., Fitamant, J., Bardeesy, N., Mou, F., & Barrufet, L. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.07.002 · Cited by 228
“[13] Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G.”
Poon, C. L. C., Lin, J. I., Zhang, X., & Harvey, K. F. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.012 · Cited by 227
The Hippo Pathway in Heart Development, Regeneration, and Diseases
Zhou, Q., Li, L., Zhao, B., & Guan, K.-L. (2015) · Circulation Research · doi:10.1161/circresaha.116.303311 · Cited by 219
Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
Zheng, Y., Wang, W., Liu, B., Deng, H., Uster, E., & Pan, D. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.08.014 · Cited by 219
“…using mosaic flies have identified Hpo, Sav, Wts, and Mats as main constituents of the core kinase cassette (Harvey et al., 2003; Justice et al., 1995; Kango-Singh et al., 2002; Lai et al., 2005; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003; Xu et al., 1995).”
Badouel, C., Gardano, L., Amin, N., Garg, A., Rosenfeld, R., Le Bihan, T., & McNeill, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.010 · Cited by 210
“Develo vates the NDR family kinase Warts (Wts) (Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003).”
BackgroundMob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Wei, X., Shimizu, T., & Lai, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601630 · Cited by 205
Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade
Zhang, Q., Meng, F., Chen, S., Plouffe, S. W., Wu, S., Liu, S., Li, X., Zhou, R., Wang, J., Zhao, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3496 · Cited by 205
“The Hippo pathway was originally discovered in Drosophila and is highly conserved 28–31 .”
BackgroundThe Hippo signaling pathway in development and regeneration
Zhong, Z., Jiao, Z., & Yu, F.-X. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113926 · Cited by 200
RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., & Pfeifer, G. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.055 · Cited by 200
Metadata
- Authors
- Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C., & Halder, G.
- Affiliations
- Baylor College of Medicine (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Halder, Georg
- Venue
- Nature Cell Biology
- Published
- 2003-09-21
- Volume
- 5
- Issue
- 10
- Pages
- 914-920
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2033440293
- Cited by
- 747
- References
- 34
- Citations by year
- 2026: 31 · 2025: 25 · 2024: 35 · 2023: 26 · 2022: 41 · 2021: 45 · 2020: 53 · 2019: 32 · 2018: 55 · 2017: 34 · 2016: 37 · 2015: 46 · 2014: 36 · 2013: 37 · 2012: 34
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- BearWorks (Missouri State University) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- National Cancer Institute (CA-16672, P30CA016672)
- National Institute of General Medical Sciences (R01GM067997, GM067997)
- National Institute of Environmental Health Sciences (T32 ES07332, T32ES007332)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD07325)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cell proliferation, apoptosis, cyclin E, DIAP1, head involution defective, Warts kinase, Ste20-like kinase, Drosophila development, cell number regulation
- MeSH terms
- Hippo Kinases, Animals, Cell Division, Drosophila melanogaster, Female, Male, Morphogenesis, Protein Kinases, Wings, Animal, Signal Transduction, Apoptosis, Protein Serine-Threonine Kinases, Cell Cycle Proteins, MAP Kinase Kinase Kinases, Saccharomyces cerevisiae Proteins, Drosophila Proteins, Animals, Genetically Modified, Intracellular Signaling Peptides and Proteins, Inhibitor of Apoptosis Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.